Keyphrases
Pantothenate Kinase-associated Neurodegeneration
64%
PANK2
50%
Neurodegeneration with Brain Iron Accumulation
43%
Hallervorden-Spatz Syndrome
33%
Neurodegenerative Diseases
20%
Globus Pallidus
16%
Dystonia
14%
Basal Ganglia
14%
Neurodegeneration
13%
Brain Iron
13%
Magnetic Resonance Imaging
12%
Coenzyme A
12%
Eye-of-the-tiger Sign
11%
Metabolism
10%
Neuroaxonal Dystrophy
10%
PLA2G6
10%
Clinical Features
9%
WDR45B
9%
PLA2G6-associated Neurodegeneration
9%
Autosomal Recessive
8%
Pigmentary Retinopathy
8%
Pantothenate
8%
PANK2 mutation
7%
Hyperintensity
7%
T2-weighted Imaging (T2WI)
7%
Hypointense
7%
FA2H
7%
MRI Changes
7%
Iron Accumulation
7%
Movement Disorders
7%
Brain MRI
7%
Dysarthria
6%
Phospholipase A2 (PLA2)
6%
Pathognomonic
6%
Imaging Changes
5%
Radiographic Features
5%
Coenzyme A Biosynthesis
5%
Medicine and Dentistry
Pantothenate Kinase-Associated Neurodegeneration
100%
Disease
40%
Neurodegeneration
26%
Dystonia
16%
Globus pallidus
14%
Magnetic Resonance Imaging
14%
Pantothenate Kinase 2
13%
Iron
12%
Pantothenic Acid
11%
Pantothenate Kinase
10%
Coenzyme A
9%
Basal Ganglia
8%
Neurodegenerative Disorder
8%
Infantile Neuroaxonal Dystrophy
6%
Hidrotic Ectodermal Dysplasia
6%
Cobalamin
6%
Retinopathy
6%
Genetic Disorder
5%
Dysarthria
5%
Stereotypic Movement Disorder
5%
Magnetic Resonance Imaging of Brain
5%
Biochemistry, Genetics and Molecular Biology
Pantothenate Kinase
67%
Coenzyme A
29%
Genetics
27%
Metabolic Pathway
21%
PLA2G6
15%
Beta-Propeller
15%
PANK2 (Gene)
12%
WDR45
9%
Dysplasia
9%
Mouse
9%
Autosomal Recessive Inheritance
8%
Tumor Spheroid
8%
Autophagy
8%
Intellectual Disability
7%
Exome Sequencing
7%
Gene Linkage
7%
Phosphopantetheine
7%
Molecular Genetics
6%
Founder Effect
6%
Haplotype
5%
Precursor
5%
Autosomal Dominant Inheritance
5%
Anabolism
5%
Membrane Protein
5%
